<DOC>
	<DOC>NCT01146275</DOC>
	<brief_summary>Several subjects included in a Pilot study (CTN 31GB0106) during 2002-2003 still had Macrolane deposits in the breast when the last study visit was performed. An additional follow up visit is planned to follow duration and safety of the former formulation of Macrolane that was used in the Pilot study (CTN 31GB0106).</brief_summary>
	<brief_title>A 7-year Follow up of All Subjects Incuded in Protocol 31GB0106</brief_title>
	<detailed_description>All subjects included in a Pilot study between 2002-2003 (CTN 31GB0106) are offered to take part in a seven year safety follow up after the initial injection of the former formulation of Macrolane into the breasts. The study will not involve any additional treatments. The follow up will include relevant medical history, weight, breast examination, ultrasound and mammography to determine if there are/have been any safety issues since the final study visit in the Pilot study (CTN 31GB0106), as well as a comprehensive MRI investigation to assess the breast structure and determine if there are still deposits of Macrolane in the breast.</detailed_description>
	<criteria>Participant in 31GB0601 There are no exclusion citeria in this study</criteria>
	<gender>Female</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>November 2013</verification_date>
	<keyword>Patients who participated in pilot study (31GB0601) and performed breast augmentation with previous formulation of Macrolane</keyword>
</DOC>